A randomised double-blind study of the effect of cranberry juice in decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing pelvic radiotherapy for cancer of bladder or cervix

Greater Glasgow NHS Board, North Glasgow Division (UK)0 个研究点目标入组 250 人开始时间: 2005年9月16日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Patients with cervical cancer about to start standard chemoradiation (weekly cisplatin chemotherapy plus radiation therapy as below) or radiation therapy (4300-4500 cGy over 20 fractions +/-selectron radiotherapy)
•2. OR patients with bladder cancer about to commence standard radical radiotherapy (5000-5240 cGy over 20 fractions).
•3. Age = 18 years.
•4. ECOG performance status = 2.
•5. Written informed consent and the ability to comply with the requirements of the study.

•1. Pregnant or lactating women are excluded. Female patients of child-bearing potential are eligible provided they have a negative urine pregnancy test prior to enrolment and agree to use approved contraceptive precautions during the trial and for 6 months afterwards.
•2. Patients with irritable bowel syndrome (they may experience episodes of diarrhoea as a side effect of drinking cranberry juice).
•3. Patients who are diabetic (due to the high sugar content of the juice).
•4. Patients who have rheumatoid arthritis (the acidic juices may exacerbate joint pain).
•5. Patients with urinary symptoms or urinary tract infections at baseline.
•6. Patients receiving antispasmodics or antibiotics for urinary symptoms.
•7. Patients with an indwelling urinary catheter.

发起方

Greater Glasgow NHS Board, North Glasgow Division (UK)